ARENSIA Exploratory Medicine

ARENSIA Exploratory Medicine, a German-based company, is a leader in "first-in-patient" Phase IB and II/Proof-of-Concept clinical trials across a wide range of disease areas.

With 14 proprietary research clinics and cutting-edge Phase I infrastructure, ARENSIA accelerates the early detection of efficacy signals for new therapies at an unparalleled speed. Its streamlined, highly efficient approach, reduces patient recruitment time and costs compared to conventional trial sites, which are often overcrowded and understaffed. This exceptional performance has resulted in a 93% repeat business rate and robust growth through collaborations with top pharmaceutical companies, biotechs, and global CROs.

Headquartered in Düsseldorf, ARENSIA operates with a team of 600 professionals across 8 countries. More details on our corporate website: https://www.arensia-em.com/